Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients’ lives and provide an attractive return on investment.
Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.
Karolinska Development has established a portfolio of 10 companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.
The Company is led by a team including investment professionals with strong venture capital backgrounds, experienced company builders and entrepreneurs, with access to a strong global network.
For more information, please visit www.karolinskadevelopment.com
Location: Sweden, Solna kommun
Employees: 1-10
Founded date: 2003
Investment Type: Venture Capital
Portfolio 9
| Date | Name | Website | Total Raised | Location |
| 29.03.2022 | AnaCardio | anacardio.... | $22.56M | Sweden, So... |
| - | OssDsign | ossdsign.c... | $48.74M | Sweden, Up... |
| - | Umecrine C... | umecrineco... | - | Burkina Fa... |
| - | Forendo Ph... | forendo.co... | $13.93M | - |
| - | Dilafor AB | dilafor.co... | - | - |
| - | Aprea | aprea.com | $114.76M | - |
| - | Biosergen ... | biosergen.... | - | - |
| - | Promimic | promimic.c... | $1.54M | Sweden, Mö... |
| - | Modus Ther... | modustx.co... | $23.13M | Sweden, St... |
Persons 108
| Date | First Name | Last Name | Title | Location | |||
| - | Johan | Dighed | Chief Lega... | - | - | - | |
| - | Eva | Montgomeri... | Head of Ac... | linkedin.c... | - | - | - |
| - | Yan | Cheng | President ... | - | - | - | |
| - | Elisabet | Gimbringer | Financial ... | - | - | - | |
| - | Viktor | Drvota | Chief Exec... | linkedin.c... | - | - | - |
| - | Elisabet | Gimbringer | Financial ... | - | - | - | |
| - | John | Öhd | Chief Scie... | - | - | - | |
| - | Per | Aniansson | Investment... | - | - | - | |
| - | Johan | Dighed | Chief Lega... | - | - | - | |
| - | Linda | Spahiu | Investment... | - | - | - |
Show more
Mentions in press and media 6
| Date | Title | Description | Source |
| 21.05.2021 | KAROLINSKA DEVELOPMENT AB (PUBL) Karolinska Development : p... | STOCKHOLM, SWEDEN 21 May 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today th... | marketscre... |
| 22.04.2021 | KAROLINSKA DEVELOPMENT AB (PUBL) Karolinska Development : p... | STOCKHOLM, SWEDEN 22 April 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today ... | marketscre... |
| 28.04.2017 | Novartis vet named CMO at Rgenix; Ophthotech promotes Sb... | Harold “Barry” Selick → UCSF hired Harold “Barry” Sellick as its new vice chancellor to nurtu... | endpts.com... |
| 21.04.2017 | Celgene grabs more space in Cambridge; Karolinska Dev ge... | → Fast-growing Celgene is expanding its footprint in Cambridge, MA, reports the Boston Busin... | endpts.com... |
| 22.03.2017 | Neurocrine fleshes out its PhIII case for valbenazine;... | → Neurocrine has already posted the key late-stage data that it took to the FDA in building a ... | endpts.com... |
| 29.06.2010 | Karolinska Development and Kurma Biofund Sign Strategic Agre... | Karolinska Development AB, a Solna, Sweden-based life science investor, and Kurma Biofund, a venture... | finsmes.co... |